• Most Popular
  • Most Shared

GlaxoSmithKline prunes new drug pipeline

Mon Oct 15, 2007 6:11am EDT

Stocks

   

LONDON, Oct 15 (Reuters) - GlaxoSmithKline Plc (GSK.L) said on Monday it had dropped a number of experimental medicines from development, including 10 products from Phase I studies, nine from Phase II and one -- Ariflo -- from Phase III.

Stocks

The terminations were offset, however, by a decision to advance several new compounds into initial clinical testing and the progress of certain assets into mid-stage clinical trials.

Europe's largest drugmaker, giving a regular update on its drug pipeline, said it still had 30 assets in late-stage development.

Stocks


More from Reuters

Photo

Obama says U.S. will pursue plane attackers

KAILUA, Hawaii (Reuters) - A wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane, and President Barack Obama vowed to bring "every element" of U.S. power against those who threaten Americans' safety. | Video

» More Top News
A young Kamchatka brown bear plays in its enclosure at the 'Tierpark Hagenbeck' zoo in Hamburg September 20, 2007. REUTERS/Christian Charisius

The return of the Russian bear

Jason Bush

As Russia's memories of crippling economic times fade, are reforms disappearing along with them?  Commentary 

Breakingviews
Surgeons extract the liver and kidneys of a brain-dead woman for organ transplant donation at the Unfallkrankenhaus Berlin (UKB) hospital in Berlin January 12, 2008. REUTERS/Fabrizio Bensch

Desperate, duped, or both

One of the world's largest organ trade hubs is moving to stop the living from cashing in their body parts.  Full Article 

Health